Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Classical hematology 1CNS 1

Conditions

Neuroblastoma 16Central Nervous System Neoplasms 13Brain Neoplasms 9Medulloblastoma 8Rhabdoid Tumor 6Astrocytoma 6Sarcoma 5Glioma 5Oligodendroglioma 4Lymphoma 4Pinealoma 3Osteosarcoma 3Optic Nerve Glioma 3Ependymoma 3Testicular Neoplasms 2Testicular Germ Cell Tumor 2Teratoma 2Spinal Cord Neoplasms 2Rhabdomyosarcoma 2Recurrence 2Ovarian Neoplasms 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasms, Germ Cell and Embryonal 2Neoplasms 2Kidney Neoplasms 2Glioblastoma 2Ganglioneuroblastoma 2Familial ependymoma 2Drug-Related Side Effects and Adverse Reactions 2Choroid Plexus Neoplasms 2

Interventions

Cyclophosphamide 3liposomal amphotericin B 2Thiotepa 2Rituximab 2Psychiatric Rehabilitation 2Fentanyl 2Etoposide 2Early Intervention, Educational 2Caspofungin 2Carboplatin 2sodium thiosulfate 1sargramostim 1pegfilgrastim 1imetelstat 1etoposide phosphate 1entinostat 1carboxyamido-triazole 1Whole-Body Irradiation 1Voriconazole 1Radiotherapy 1Positron-Emission Tomography 1Pentetic Acid 1Pemetrexed 1Paclitaxel 1Oxycodone 1Nicotine 1Morphine 1Minocycline 1Methotrexate 1Methadone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Intraocular Lymphoma × etoposide phosphate × CNS × Clear all
NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡